Description: Advicenne S.A., a specialty pharmaceutical company, develops and commercializes treatments for nephrology. Its lead product candidate is Sibnayal for the treatment of distal renal tubular acidosis, as well as for the treatment of cystinuria. Advicenne S.A. was founded in 2007 and is headquartered in Paris, France.
Home Page: www.advicenne.com
3ème étage 262
Paris,
75008
France
Phone:
33 1 85 73 36 20
Officers
| Name | Title |
|---|---|
| Ms. Caroline Roussel-Maupetit | Co-Founder, Director of Operations & GM |
| Mr. Paul Michalet | Chief Financial Officer |
| Mr. Ludovic Robin M.B.A., Pharm.D. | Chief Bus. Officer |
| Ms. Nathalie Lemarié | Chief Pharmacist & Director of Regulatory Affairs |
| Dr. André Ulmann M.D., Ph.D. | Chief Medical Officer & Non-Voting Director |
| Mr. Didier Laurens | CEO & Director |
| Dr. David Horn Solomon M.D. | Pres |
| Ms. Catherine Guittet | Head of Clinical Operations Department |
| Mrs. Catherine Martre | Head of Strategy & Commercial Devel. |
Exchange: PA
Country: FR
Currency: Euro (€)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 127.7049 |
| Price-to-Sales TTM: | 10.4941 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 26 |